Halozyme Therapeutics, Inc. (HALO)
NASDAQ: HALO · Real-Time Price · USD
76.90
-0.63 (-0.81%)
At close: Sep 12, 2025, 4:00 PM EDT
76.12
-0.78 (-1.02%)
After-hours: Sep 12, 2025, 7:12 PM EDT
Period EndingJun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018
Royalties
699.31M618.59M570.99M522.62M482.00M468.82M447.87M431.79M
Royalties Growth
45.09%31.95%27.49%21.04%15.61%20.05%24.24%36.16%
Product Sales
325.57M322.95M303.49M303.73M303.64M298.64M300.85M282.42M
Product Sales Growth
7.22%8.14%0.88%7.55%18.02%30.02%57.49%79.98%
Revenues Under Collaborative Agreements
153.79M142.77M140.84M121.00M87.67M95.53M80.53M66.50M
Revenues Under Collaborative Agreements Growth
75.42%49.45%74.88%81.95%-11.86%12.67%-25.85%-37.60%
Period EndingJun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018
Cost of Sales
186.24M179.49M159.42M169.66M175.06M185.52M192.36M182.18M
Cost of Sales Growth
6.39%-3.25%-17.13%-6.87%0.22%17.01%38.09%53.39%
Selling, General, and Administrative
167.47M161.56M154.34M149.69M143.72M146.96M149.18M149.32M
Selling, General, and Administrative Growth
16.52%9.94%3.45%0.25%-3.23%-12.03%3.94%24.90%
Research and Development
71.24M74.74M79.05M79.94M78.81M77.50M76.36M77.59M
Research and Development Growth
-9.60%-3.56%3.52%3.03%2.38%6.55%14.65%43.30%
Amortization
71.05M71.05M71.05M71.05M73.63M73.70M73.77M60.56M-----------------
Amortization Growth
-3.50%-3.60%-3.69%17.31%9.22%20.85%-------------------
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.